Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies
β Scribed by R.M Ruprecht; R Hofmann-Lehmann; B.A Smith-Franklin; R.A Rasmussen; V Liska; J Vlasak; W Xu; T.W Baba; A.L Chenine; L.A Cavacini; M.R Posner; H Katinger; G Stiegler; B.J Bernacky; T.A Rizvi; R Schmidt; L.R Hill; M.E Keeling; D.C Montefiori; H.M McClure
- Book ID
- 117742138
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- French
- Weight
- 108 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1246-7820
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Human monoclonal antibodies (mAbs) generated as a result of the immune response are likely to be the most effective therapeutic antibodies, particularly in the case of infectious diseases against which the immune response is protective. Human cytomegalovirus (HCMV) is an ubiquitous oppo
## Abstract We have previously reported that concanavalin Aβimmobilized polystyrene nanospheres (Con AβNS) could efficiently capture HIVβ1 particles and that intranasal immunization with inactivated HIVβ1βcapturing nanospheres (HIVβNS) induced vaginal antiβHIVβ1 IgA antibody response in mice. In th